Growth Metrics

Edwards Lifesciences (EW) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -2.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -472.46%
Dec 31, 2025 -59.97%
Sep 30, 2025 -28.53%
Jun 30, 2025 -49.30%
Mar 31, 2025 -28.10%
Dec 31, 2024 15.79%
Sep 30, 2024 109.22%
Jun 30, 2024 33.49%
Mar 31, 2024 48.42%
Dec 31, 2023 27.12%
Sep 30, 2023 39.33%
Jun 30, 2023 107.10%
Mar 31, 2023 26.07%
Dec 31, 2022 30.31%
Sep 30, 2022 -151.28%
Jun 30, 2022 51.36%
Mar 31, 2022 87.92%
Dec 31, 2021 -455.54%
Sep 30, 2021 -14.08%
Jun 30, 2021 -72.59%
Mar 31, 2021 -30.56%
Dec 31, 2020 -93.74%
Sep 30, 2020 15.52%
Jun 30, 2020 74.81%
Mar 31, 2020 -42.45%
Dec 31, 2019 -96.20%
Sep 30, 2019 -73.87%
Jun 30, 2019 36.39%
Mar 31, 2019 -44.97%
Dec 31, 2018 -40.68%
Sep 30, 2018 -13.12%
Jun 30, 2018 103.21%
Mar 31, 2018 47.70%
Dec 31, 2017 -23.93%
Sep 30, 2017 -10.61%
Jun 30, 2017 -10.70%
Mar 31, 2017 48.31%
Dec 31, 2016 32.47%
Sep 30, 2016 26.76%
Jun 30, 2016 -67.51%
Mar 31, 2016 51.14%
Dec 31, 2015 -0.12%
Sep 30, 2015 -10.01%
Jun 30, 2015 31.86%
Mar 31, 2015 -66.74%
Dec 31, 2014 44.77%
Sep 30, 2014 -68.68%
Jun 30, 2014 -34.02%
Mar 31, 2014 8.83%
Dec 31, 2013 -120.28%
Sep 30, 2013 -91.35%
Jun 30, 2013 -63.51%
Mar 31, 2013 60.15%
Dec 31, 2012 54.99%
Sep 30, 2012 -64.79%